期刊文献+

西地那非对慢性心力衰竭患者治疗效果及安全性的Meta分析 被引量:2

Effects and safety of Sildenafil in patients with systolic heart failure-Meta analysis
下载PDF
导出
摘要 目的 评价磷酸二酯酶抑制剂西地那非治疗慢性充血性心力衰竭的效果及安全性.方法 通过检索Pubmed、EMBASE、Cochrane、中国生物医学文献数据库、中文期刊文献数据库、万方数据库文献,手工检索已纳入相关的参考文献.纳入西地那非与安慰剂对照、治疗周期超过4周、左室射血分数降低的随机对照研究,经质量评估、数据提取,进行Meta分析.结果 纳入7项随机对照研究,共计315例观察对象,301例完成超过4周随访,其中治疗组153例、对照组148例.分析结果显示,治疗组左室射血分数[均数差=3.75,95%可信区间1.43~6.06,P<0.01]和峰值氧耗量[均数差=2.92,95%可信区间为1.48~4.36,P<0.01]增加,二氧化碳通气当量斜率降低[均数差=-5.93,95%可信区间为-7.19~-4.67,P<0.01],肺动脉收缩压[均数差=-12.97,95%可信区间为-17.42~-8.51,P<0.01]、肺动脉平均压[均数差=-6.21,95%可信区间为-12.08~-0.34,P<0.05]、肺毛细血管口压[均数差分别为-3.57 (P<0.01)和-89.96(P<0.01),95%可信区间分别为-6.12~.1.01和-121.50~-58.42]和肺循环阻力[均数差=-89.96,可信区间为-121.50~-58.42,P<0.01]均明显降低.西地那非对右房压和周围血管阻力无明显影响,对慢性心力衰竭生活质量评估积分无明显影响.治疗中患者血压、心率平稳,无心律失常;主要副作用为头痛.结论 慢性心力衰竭患者选择性使用西地那非可以明显改善心肺功能,无明显副作用,长期使用患者有良好的耐受性. Objective Our study aimed to assess the efficacy and safety of phosphodiesterase type 5 inhibitor (PDE5) Sildenafil in the patients with systolic heart failure.Methods We performed a systemic searched and identified in the Pubmed,EMBASE,Cochrane and CBM databases to collected Randomized controlled trials (RCT) study.The reference literature was retrieved manually.Prospective RCT of Sidenfil with duration at least 4 weeks and treatment VS placebo and LVEF reduce were included.After quality assessments and data extraction all study were given meta-analysis.Results We enrolled 7 RCT study total 315 patients.301 patients were followed over 4 weeks (Sildenafil 153,placebo 148).Sildenafil showed benefits in increasing LVEF (MD=3.75,95%CI 1.43-6.06,P〈0.01) and Peak VO2 (MD=2.92,95%CI 1.48-4.36,P〈0.01) and reducing VE/VCO2 (MD=-5.93,95%CI-7.19--4.67,P〈0.01)and mean pulmonary pressure (MD=-6.21,95%CI-12.08--0.34,P〈0.05) and pulmonary capillary wedge pressure (MD=-3.57,95%CI-6.12--1.01) and pulmonary vascular resistance (MD=-89.96,95%CI-121.50--58.42,P〈0.01).There was no significantly difference in blood pressure and heart rate and arrhythmia and quality of life between tow groups.The mainly adverse was headache.Conclusion Sildenafil was curative effects in improvement function of heart.The select use was safety and well tolerated.
出处 《中国心血管病研究》 CAS 2017年第4期370-376,共7页 Chinese Journal of Cardiovascular Research
关键词 慢性心力衰竭 左室射血分数 西地那非 META分析 Chronic heart failure Left ventricular injection fraction Sildenafil Meta analysis
  • 相关文献

参考文献1

二级参考文献26

  • 1朱燕波,折笠秀树,郑洁,杜金行.慢性心功能不全患者的生活质量[J].中国临床康复,2004,8(15):2928-2929. 被引量:14
  • 2严俊峰,龚开政.慢性心力衰竭患者健康相关生存质量的研究进展[J].中国康复医学杂志,2004,19(11):871-873. 被引量:7
  • 3Berry C, Mcmurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmaeoeconomics, 1999, 16: 247-271.
  • 4Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association. Circulation, 2010 : e2-e192.
  • 5Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care, 1989, 27 (3 Suppl) : S217-S232.
  • 6Banegas JR, Rodriguez-Artalejo F. Heart failure and instruments for measuring quality of life. Rev Esp Cardiol, 2008, 61: 233- 235.
  • 7Rector TS,Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure, 1987, 3: 198-209.
  • 8Wiklund I,Lindvall K, Swedberg K, et al. Self-assessment of quality of life in severe heart failure. An instrument for clinical use. Scand J Psychol, 1987, 28: 220-225.
  • 9Guyatt GH, Nogradi S, Halcrow S, et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med, 1989,4: 101-107.
  • 10Spertus JA,Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire : a new functional status measure for coronary artery disease. J Am Coil Cardiol, 1995,25 : 333-341.

共引文献10

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部